(Alliance News) - The FTSE 100 struggled for direction on Wednesday, despite progress elsewhere, as investors digested another earnings deluge and looked ahead to the US rate call and earnings from technology titans Meta Platforms and Microsoft. Read More
(Alliance News) - The FTSE 100 went into the afternoon lower on Wednesday, though blue-chip peers in Europe were on the up and stocks in New York are called to open higher with a decisive few days on the horizon stateside. Read More
(Alliance News) - GSK said it expects annual sales growth at the top end of its outlook range, after "another quarter of excellent performance" saw revenue and profit beat forecasts. Read More
(Alliance News) - GSK predicted an annual outturn at the top end of guidance, BAE Systems maintained its outlook, while Aston Martin softened its profit forecast. Read More
(Alliance News) - Equities in Europe started the week strongly, after the US and EU agreed a trade deal and on hope that the Donald Trump administration can extend a tariff pause with China. Read More
(Alliance News) - GSK PLC on Monday said it has teamed up with China's Jiangsu Hengrui Pharmaceuticals Co Ltd in a deal worth up to USD12 billion to develop 12 medicines. Read More
(Alliance News) - GSK announced a partnership with China's Hengrui, Cranswick said it expects results in line with market expectations, while STV warned of an annual outcome below consensus. Read More
(Alliance News) - GSK PLC on Thursday said its Blenrep blood cancer treatment has been approved in Europe, as it awaits a final decision from the US regulator. Read More
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory committee last week voted against the overall benefit/risk profile of the drug. Read More
(Alliance News) - Stock prices in London closed higher on Friday, with markets maintaining the optimism that prevailed after US President Donald Trump said on Wednesday that it was "highly unlikely" that he would fire Federal Reserve Chair Jerome Powell. Read More
(Alliance News) - Stock prices in Europe were largely higher at midday on Friday, though the FTSE 100 pared some earlier gains as a slump from GSK weighed on the index. Read More
(Alliance News) - Stock prices in Europe opened higher early on Friday, with the FTSE 100 almost hitting a new record high, as a swathe of dealmaking was well-received in London. Read More
(Alliance News) - GSK PLC on Thursday noted that the US Food & Drug Administration Oncologic Drugs Advisory Committee voted against the overall benefit/risk profile at the proposed dosage of Blenrep combinations. Read More
(Alliance News) - GSK PLC on Thursday said the prefilled syringe version of its vaccine Shingrix has been approved for use in the US for the prevention of shingles. Read More
(Alliance News) - GSK PLC on Monday said it has submitted a US regulatory application for the expanded use of its Arexvy respiratory syncytial virus vaccine. Read More
(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RSV jab, while South32 warned of an impairment at an aluminium smelter in Mozambique. Read More
(Alliance News) - London's FTSE 100 closed a winning week on the back foot after soft economic growth figures and threats of further tariffs from the US. Read More
